Health & Medicine

The John G. FitzGerald Award recognizes Smieja for advancing the diagnosis and epidemiology of respiratory and gastrointestinal infections, including those caused by SARS-CoV-2, influenza, rhinovirus, and C. difficile.

New research suggests that fine particles from traffic, industry and wildfire smoke are linked to worse cognitive function.

The drug candidate can eliminate deadly and aggressive glioblastoma tumours, which typically resist standard treatments and often recur rapidly.

New “organ-on-a-chip” technology offers alternative to animal studies.

With flimsy or no evidence that using unauthorized peptide drugs is effective in humans, buying the online and self-injecting is high-risk, uncontrolled human self-experimentation, writes Stuart Phillips.

The funding will power even closer ties between Stoked Bio Inc and the Stokes Lab at McMaster as they propel a suite of new drug candidates toward the clinic.

Useful science and ambitious science are points along the same continuum, write Shay Freger and Matthew Leonardi: Today’s basic research becomes tomorrow’s applied science.

Professors Lehana Thabane, Megan Brickley, Parminder Raina and Hendrik Poinar will be formally recognized at Spring convocation ceremonies.

McMaster researchers are part of an international team of scientists whose discovery of the insect toxin has the potential to better protect humans from infectious disease and crops from pests.

Beyond the Breakthroughs highlighted initiatives led by innovation accelerator NexusHealth and plans for the new BioInnovation Building on campus. 

The prestigious Bernhard Cinader Award recognizes Kaushic’s exceptional contributions to research on STIs and women’s reproductive health. 

Nicole Fröhlich first came to McMaster as an undergraduate visiting researcher from Brazil. Now, her master's project is trying to find blood-based biomarkers that could help us better understand the neurobiological underpinnings of bipolar disorder.